All shareholders of record owning USEI common shares on the Record Date of December 29, 2014 shall receive a 20% dividend which translates to 1 (one) share of USEI common stock for every 5 (shares) shares held by such shareholder. For example, if a shareholder owns 500,000 shares of USEI common stock at the close of business on December 29, 2014, that shareholder shall receive 100,000 additional shares of USEI common stock, giving that shareholder a total of 600,000 shares.

According to Anthony Miller, CEO, "We have decided to award all of our loyal shareholders with this additional stock because they have stuck with us through our transitional phases. Many of our shareholders have held this stock in excess of 6 years, and they along with newer shareholders, will now become beneficiaries of our anticipated growth. In 2014 we moved into the cannabis industry and have had some success (two CBD stores opened and a host of branded cannabis related products) and we believe that many of the initiatives we have started this past year will reap rewards in 2015. Management will continue to focus on its energy initiatives as well in 2015. This firm is an energy company at its core and the company's oil & gas technologies, our green energy relationships (biodiesel & hemp) and our strategic partnerships will continue to become a significant part of our efforts in 2015. It is our goal in 2015 to split our efforts on both business segments and management has a significant plan to do this. The management would like to personally thank all of the shareholders of record of US Energy Initiatives Corporation, Inc for all of your support over the last few years, and it is our goal to wake up every morning to attempt to build the best energy and cannabis firm that we can; with what we have before us. We are excited about the directions that we are headed and will continue to press on; till we reach our goals and objectives... further commented Miller."

About U.S. Energy Initiatives: U.S. Energy Initiatives Corporation (OTC PINK: USEI) is a diverse energy firm. USEI and its wholly owned subsidiary USEI Cannabis' business centers on hemp to energy, everything cannabis related and developing products and services for the marketplace. Our Ultimate Cure & Real McCoy Genuine Products: we market vapor pens and accessories, topical ointments, cannabis oils and tinctures all under these same names. Our focus in the state of Washington is currently CBD Cannabis however, we are not just focusing on CBD side of business (http://www.useicannabis.com/web/washington-partnerships/... Our online store: http://www.theuccbdshop.com/);we are actively working to obtain the ability to produce our own products, own our own recreational dispensary and grow marijuana. Our goal here is to become an environmentally responsible firm, marketing our products to our audience to produce significant revenue and add value for our shareholders. We have very ambitious goals and objectives for USEI Cannabis and we believe that we will have a very long presence in Washington and Oregon, and wherever cannabis is legal. Our objective is to create a foundation that will be instrumental in our continued efforts to capture our market-share and create viable products that meet our goals and objectives for these markets. For more information regarding our strategies it can be found on the company's website @ www.useicannabis.com/web/.

Cannabidiol -- CBD -- is a compound in cannabis that has significant medical effects, but does not make people feel "stoned" and can actually counter the psychoactivity of THC. The reduced psychoactivity of CBD-rich cannabis may make it an appealing treatment option for patients seeking anti-inflammatory, anti-pain, anti-anxiety, anti-psychotic, and/or anti-spasm effects without disconcerting lethargy or dysphoria. Scientific and clinical studies underscore CBD's potential as a treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrated neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere.

DISCLOSURES: "Safe Harbor" This press release contains forward-looking statements including statements regarding the timing of the revenue from the partnership and the partnership's success. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward looking statements include consumer reaction to our Cannabis products and new regulations which affect the distribution of these products. Further information on our risk factors is contained in our filings with the OTC Markets. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.